- Company Directors - P
- Pickett Cecil B
Insider Trading History of Pickett Cecil B
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pickett Cecil B since 2005.
The trader's CIK number is 1238308.
At the time of the last reporting, Pickett Cecil B was the President, R & D of Biogen Inc.. (stock ticker symbol BIIB).
Also see all insider trading activities at Biogen Inc..
Note that in the past
PICKETT CECIL B also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biogen Inc. (BIIB) by Pickett Cecil B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | BIIB | 0 | $0 | 26,096 | $1,409,185 | 0 | $0 |
| 2008 | BIIB | 0 | $0 | 28,162 | $1,981,448 | 0 | $0 |
Yearly summary of insider trading at Merck & Co., Inc. (SGP) by Pickett Cecil B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | SGP | 0 | $0 | 100,000 | $2,010,000 | 100,000 | $1,700,000 |
| 2005 | SGP | 0 | $0 | 11,410 | $230,288 | 0 | $0 |
Insider trading activities at 2 companies by Pickett Cecil B:
1. Biogen Inc. (BIIB)
2. Merck & Co., Inc. (SGP)
Table 1. Insider trading of Biogen Inc. (BIIB) by Pickett Cecil B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-04-08 | BIIB | Sale | 17,398 | 54.50 | 948,191 |
| 2009-02-04 | BIIB | Sale | 8,698 | 53.00 | 460,994 |
| 2008-07-23 | BIIB | Sale | 5,054 | 72.00 | 363,888 |
| 2008-07-22 | BIIB | Sale | 23,108 | 70.00 | 1,617,560 |
Table 2. Insider trading of Merck & Co., Inc. (SGP) by Pickett Cecil B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-08-25 | SGP | Sale | 100,000 | 20.10 | 2,010,000 |
| 2006-08-25 | SGP | Option Ex | 100,000 | 17.00 | 1,700,000 |
| 2005-12-13 | SGP | Sale | 5,819 | 19.60 | 114,052 |
| 2005-05-04 | SGP | Sale | 5,591 | 20.79 | 116,236 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pickett Cecil B
(President, R & D of Biogen Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.